British Journal of Medical & Surgical Urology
Volume 2, Issue 5 , Pages 191-196, September 2009

A large proportion of patients with prostate cancer undergoing androgen deprivation therapy continue to die from non-cancer causes in the PSA era

  • Vivek K. Wadhwa
    • ,
  • Robin Weston
    • ,
  • Nigel J. Parr

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Urology, Ward 14, Wirral University Teaching Hospitals, Arrowe Park, Upton, Wirral, Merseyside, CH49 5PE, UK. Tel.: +44 151 678 5111x2233; fax: +44 151 604 7481.

Department of Urology, Wirral University Teaching Hospital, Wirral, UK

Received 18 September 2008; received in revised form 9 June 2009; accepted 15 June 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1875-9742(09)00097-4

doi:10.1016/j.bjmsu.2009.06.004

British Journal of Medical & Surgical Urology
Volume 2, Issue 5 , Pages 191-196, September 2009

Article Tools

* Image Usage & Resolution